About TandemLife
TandemLife is a Healthcare company based in Pittsburgh (United States) founded in 1996 by George Magovern, and was acquired by LivaNova in February 2018. Circulatory support devices and ventricular assist systems are provided. TandemLife has raised $33 million across 1 funding round from investors including LivaNova and NeoMed. Its chief executive, as recorded, is John Marous. TandemLife offers products and services including LifeSPARC System, ProtekDuo, TandemHeart, TandemLung, and TandemLife. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is LivaNova, Inc. Its competitors include CVRx, HeartWare and Element Science; 3 of its 3 listed competitors have raised funding.
Company details
TandemLife, founded in 1996 and based in Pittsburgh, United States, operates in the cardiovascular medical device sector. Temporary ventricular circulatory support devices for post-cardiotomy cardiac failure are developed, along with a Tandem Lung oxygenator for blood oxygenation and carbon dioxide removal. Hydrodynamic centrifugal pumps, transseptal cannulas for left ventricular assist, and electromechanical systems are also produced. The company rebranded from CardiacAssist in 2016.
- Headquarters Pittsburgh, United States
- Founders George Magovern
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tandemlife.com
- Social LinkedIn X Facebook
- Acquired by LivaNova (Feb 2018)
- Legal Name Livanova, Inc.
Products & Services of TandemLife
TandemLife offers a comprehensive portfolio of products and services, including LifeSPARC System, ProtekDuo, TandemHeart, TandemLung, and TandemLife.
Provides advanced support for critical care patients during procedures.
Enables dual circulatory assistance in medical interventions.
Offers temporary heart support for surgical and emergency use.
Assists lung function in critical respiratory conditions.
Combines heart and lung support for comprehensive care.
Includes essentials for circulatory support procedures and setups.
Funding Insights of TandemLife
TandemLife has successfully raised a total of $33M through 1 strategic funding round. The most recent funding activity was a Series C round of $33 million completed in February 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33M
- Total Rounds 1
- Last Round Series C — $33M
- First Round $33M
(Feb 2001)
- Investors Count 1
All 1 funding rounds of TandemLife with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2001 | $33M | Series C | – | – |
2 investors in total: 2 institutional.
Investors in TandemLife
TandemLife has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include LivaNova and NeoMed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stage-agnostic life sciences-focused VC firm investing in North America & Europe | neomed.net | Oslo, Norway | ||
Therapeutic devices for cardiac and neurological conditions are provided worldwide. | 2015 | livanova.com | London, United Kingdom |
Investor details for TandemLife
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TandemLife
242 people are tracked at TandemLife (84 in leadership, 7 in board & advisors, 151 in team).
| Name | Role | Group |
|---|---|---|
George Magovern | Co-Founder & Director | Leadership |
John Marous | CEO & President | Leadership |
Pim Wagnon | Vice President - Treasury, Credit & Risk Management | Leadership |
Rufus Carter | Competitive Intelligence And Data Analytics Director | Leadership |
Michael Hutchinson | SVP, Chief Legal Officer & Company Secretary | Leadership |
Vincenzo Incorvaia | Finance Director - R&d Business Partner | Leadership |
Paolo Paoletti | VP Finance, Cardiopulmonary Business Unit | Leadership |
Alex Shvartsburg | CFO | Leadership |
Stephanie Bolton | President, Global Epilepsy | Leadership |
Liz Fortier | Chief Privacy & Data Governance Officer | Leadership |
Terra Buckley | Chief Compliance Officer | Leadership |
Ben Lang | Director, Global HR Systems & HR PMO | Leadership |
Belle Smith | Operations Director | Leadership |
Cristiano Guglielmi | VP Quality, Cardiopulmonary And International | Leadership |
Dr. Michael Jaeger | Vice President Global Operations Cardiopulmonary | Leadership |
Andrew Briggs | Senior Director - Strategy & Analytics | Leadership |
Francesca D'Ambrosio | Senior Director Operations | Leadership |
Becky P. | Director, International Sales Force Effectiveness/commercial Excellence | Leadership |
Jessica Long | Senior Director | Sustainability ESG │ Global Transformation Owner | Leadership |
William Kozy | Interim CEO & Chair | Leadership |
222 more people are available in the full profile.
Complete people profiles for TandemLife
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TandemLife
3 dated milestones of TandemLife across 22 years, from founding to its latest funding, stage changes and deals.
- Founded TandemLife is founded.
- Funding First funding round of $33.0M.
- Exit Acquired by LivaNova.
Competitors of TandemLife
TandemLife has 3 listed competitors in our database, 3 of them funded. They include CVRx, HeartWare and Element Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cvrx.com | 2001 | Minneapolis, United States | $368.5M | 142 | Implantable technology for hypertension and heart failure is developed. | |
| heartware.com | 2005 | Framingham, United States | $12.38M | 547 | Miniaturized ventricular assist devices are developed for heart failure treatment. | |
| elementscience.com | 2013 | San Francisco, United States | $192.6M | Wearable patch defibrillators are developed for sudden cardiac arrest treatment. |
Detailed competitors of TandemLife
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as TandemLife (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tandemlife
Complete news archive for TandemLife
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TandemLife
TandemLife was founded in 1996 and raised its 1st funding round 5 years after it was founded.
TandemLife is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
John Marous is the CEO of TandemLife, as recorded in our data.
TandemLife is a funded company, having raised a total of $33M across 1 funding round to date. The company's 1st funding round was a Series C of $33M, raised on Feb 2001.
TandemLife, founded in 1996 and based in Pittsburgh, United States, operates in the cardiovascular medical device sector. Temporary ventricular circulatory support devices for post-cardiotomy cardiac failure are developed, along with a Tandem Lung oxygenator for blood oxygenation and carbon dioxide removal. Hydrodynamic centrifugal pumps, transseptal cannulas for left ventricular assist, and electromechanical systems are also produced. The company rebranded from CardiacAssist in 2016.
TandemLife's top competitors include CVRx, Element Science and HeartWare.
TandemLife offers LifeSPARC System, ProtekDuo, TandemHeart, TandemLung, and 2 more products and services.
TandemLife operates through Livanova, Inc..
Yes. TandemLife was acquired by LivaNova in February 2018.